A prospective, randomised, blinded pilot study comparing the Sunrise solution and overnight polygraphy for the diagnosis of OSA in adult patients. Patients under investigation for OSA will use both devices simultaneously for a single overnight sleep study. They will be randomised to receive their treatment decision based on either the Sunrise solution or polygraphy. A retrospective check of their diagnosis will be done.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Enrollment
40
Sunrise (Sunrise SA, Belgium) is a novel integrated digital medicine solution for the diagnosis of OSA allowing the detection of respiratory disorders from the analysis of mandibular movements optimised by an artificial intelligence algorithm "machine learning". It is composed of a unique innovative sensor, placed on the chin during the night, connected via Bluetooth to a mobile application which guides the patients for the implementation and allows the transfer of the data collected by the sensor to a certified health host guaranteeing the security and confidentiality of medical data. The analysed data is integrated and automatically transferred into a detailed report made available to doctors via a secure website the day after the test.
Polygraphy (Apnoealink-Air, ResMed, Australia) is a commercially available, limited-channel sleep study device which can be used in the home. Many sleep services in the UK already use the ApneaLink Air for routine screening. It is a portable device which consists of a nasal cannula to measure nasal flow and snoring, oximeter to measure pulse and blood oxygen levels, and a chest band to measure respiratory effort. It contains software which allows for the scoring of apnoeas, hypopnoea and arousals.
Raigmore Hospital
Inverness, United Kingdom
Royal Brompton Hospital
London, United Kingdom
Time to treatment decision
Time (days) from sleep study device dispatch to treatment decision
Time frame: From date of sleep study device dispatch until the date of treatment decision, assessed typically within 1 month but up to 6 months
Time to treatment decision; RBH vs NHS Scotland Sleep Service
Time (days) from sleep study device dispatch to treatment decision; inner London (Royal Brompton hospital) vs Scottish Highlands (NHS Scotland Sleep Service)
Time frame: From date of sleep study device dispatch until the date of treatment decision, assessed typically within 1 month but up to 6 months
AHI
Apnoea-hypopnoea index compared between sleep study devices; Sunrise and polygraphy
Time frame: After completion of the sleep studies and data from both devices is available; typically within 1 month but up to 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.